AMS Quote, Financials, Valuation and Earnings

Biote has a net margin of -2.96% compared to American Shared Hospital Services's net margin of 20.83%. American Shared Hospital Services's return on equity of 13.75% beat Biote's return on equity of --.

American Shared Hospital Services has a consensus price target of --, signalling upside risk potential of 40.19%. On the other hand Biote has an analysts' consensus of -- which suggests that it could grow by 66.89%. Given that Biote has higher upside potential than American Shared Hospital Services, analysts believe Biote is more attractive than American Shared Hospital Services.

American Shared Hospital Services has a beta of 0.663, which suggesting that the stock is 33.72% less volatile than S&P 500. In comparison Biote has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biote offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Biote pays out 262.18% of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7M, which are smaller than Biote quarterly revenues of $51.4M. American Shared Hospital Services's net income of -$207K is lower than Biote's net income of $10.7M. Notably, American Shared Hospital Services's price-to-earnings ratio is 5.35x while Biote's PE ratio is 22.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.84x versus 1.03x for Biote. Usually stocks with elevated PS ratios are considered overvalued.

Cryo-Cell International has a net margin of -2.96% compared to American Shared Hospital Services's net margin of 8.15%. American Shared Hospital Services's return on equity of 13.75% beat Cryo-Cell International's return on equity of --.

American Shared Hospital Services has a consensus price target of --, signalling upside risk potential of 40.19%. On the other hand Cryo-Cell International has an analysts' consensus of $9.00 which suggests that it could grow by 16.13%. Given that American Shared Hospital Services has higher upside potential than Cryo-Cell International, analysts believe American Shared Hospital Services is more attractive than Cryo-Cell International.

American Shared Hospital Services has a beta of 0.663, which suggesting that the stock is 33.72% less volatile than S&P 500. In comparison Cryo-Cell International has a beta of 0.501, suggesting its less volatile than the S&P 500 by 49.887%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cryo-Cell International offers a yield of 3.23% to investors and pays a quarterly dividend of $0.25 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Cryo-Cell International pays out -- of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7M, which are smaller than Cryo-Cell International quarterly revenues of $8M. American Shared Hospital Services's net income of -$207K is lower than Cryo-Cell International's net income of $655.8K. Notably, American Shared Hospital Services's price-to-earnings ratio is 5.35x while Cryo-Cell International's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.84x versus 2.01x for Cryo-Cell International. Usually stocks with elevated PS ratios are considered overvalued.

Omnicell has a net margin of -2.96% compared to American Shared Hospital Services's net margin of 3.06%. American Shared Hospital Services's return on equity of 13.75% beat Omnicell's return on equity of -1.47%.

American Shared Hospital Services has a consensus price target of --, signalling upside risk potential of 40.19%. On the other hand Omnicell has an analysts' consensus of -- which suggests that it could grow by 30.95%. Given that American Shared Hospital Services has higher upside potential than Omnicell, analysts believe American Shared Hospital Services is more attractive than Omnicell.

American Shared Hospital Services has a beta of 0.663, which suggesting that the stock is 33.72% less volatile than S&P 500. In comparison Omnicell has a beta of 0.774, suggesting its less volatile than the S&P 500 by 22.577%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Omnicell offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Omnicell pays out -- of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7M, which are smaller than Omnicell quarterly revenues of $282.4M. American Shared Hospital Services's net income of -$207K is lower than Omnicell's net income of $8.6M. Notably, American Shared Hospital Services's price-to-earnings ratio is 5.35x while Omnicell's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.84x versus 1.86x for Omnicell. Usually stocks with elevated PS ratios are considered overvalued.

P3 Health Partners has a net margin of -2.96% compared to American Shared Hospital Services's net margin of -12.84%. American Shared Hospital Services's return on equity of 13.75% beat P3 Health Partners's return on equity of -26.35%.

American Shared Hospital Services has a consensus price target of --, signalling upside risk potential of 40.19%. On the other hand P3 Health Partners has an analysts' consensus of -- which suggests that it could grow by 241.53%. Given that P3 Health Partners has higher upside potential than American Shared Hospital Services, analysts believe P3 Health Partners is more attractive than American Shared Hospital Services.

American Shared Hospital Services has a beta of 0.663, which suggesting that the stock is 33.72% less volatile than S&P 500. In comparison P3 Health Partners has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. P3 Health Partners offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. P3 Health Partners pays out -- of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $7M, which are smaller than P3 Health Partners quarterly revenues of $362.1M. American Shared Hospital Services's net income of -$207K is higher than P3 Health Partners's net income of -$46.5M. Notably, American Shared Hospital Services's price-to-earnings ratio is 5.35x while P3 Health Partners's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.84x versus 0.02x for P3 Health Partners. Usually stocks with elevated PS ratios are considered overvalued.